← Evidence map

ArticleJAMA dermatology2019

Restrictive FDA Requirements and the Development of Generic Topical Medications-Reply.

David G Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 30810704